Murray Resnick (@murrayresnick) 's Twitter Profile
Murray Resnick

@murrayresnick

ID: 837775993179947008

calendar_today03-03-2017 21:25:36

24 Tweet

40 Followers

54 Following

Murray Resnick (@murrayresnick) 's Twitter Profile Photo

This doctor works in UCLA Health's ICU. What she's seen over the past few weeks is haunting her. huffpost.com/entry/covid-19… # via HuffPost

PathAI (@path_ai) 's Twitter Profile Photo

PathAI is excited to present our new research in AI-based UC models at #IBDInnovate hosted by Crohn's & Colitis Foundation. If you are attending the conference, catch our presentation tomorrow at 3:45 ET!

PathAI is excited to present our new research in AI-based UC models at #IBDInnovate hosted by <a href="/CrohnsColitisFn/">Crohn's & Colitis Foundation</a>. If you are attending the conference, catch our presentation tomorrow at 3:45 ET!
PathAI (@path_ai) 's Twitter Profile Photo

In case you missed us at AASLD’s #LiverMTG21, catch our latest data collaborations around AI-scoring with Bristol Myers Squibb & Novo Nordisk. See highlights below and view the full posters here: bit.ly/3oA7Naf, bit.ly/3DwaBJH

In case you missed us at AASLD’s #LiverMTG21, catch our latest data collaborations around AI-scoring with <a href="/bmsnews/">Bristol Myers Squibb</a> &amp; Novo Nordisk. See highlights below and view the full posters here: bit.ly/3oA7Naf, bit.ly/3DwaBJH
PathAI (@path_ai) 's Twitter Profile Photo

We are partnering with Akoya Biosciences ! This new partnership combines PathAI’s AI-based platforms with Akoya’s Phenoptics™ spatial phenotyping platform to provide a complete spatial biology solution for biomarker-guided drug development. bit.ly/3ykE0pn

We are partnering with <a href="/AkoyaBio/">Akoya Biosciences</a> ! This new partnership combines PathAI’s AI-based platforms with Akoya’s Phenoptics™ spatial phenotyping platform to provide a complete spatial biology solution for biomarker-guided drug development. 

 bit.ly/3ykE0pn
PathAI (@path_ai) 's Twitter Profile Photo

We had a big year in 2021, as exemplified by a few of our favorite numbers that we’ve rounded up! We’re tremendously proud of the work we’ve done for patients and the team we’ve built to keep driving our mission forward. Here’s to 2022 and growing these numbers!

We had a big year in 2021, as exemplified by a few of our favorite numbers that we’ve rounded up! We’re tremendously proud of the work we’ve done for patients and the team we’ve built to keep driving our mission forward. Here’s to 2022 and growing these numbers!
Laboratory Investigation (@lijournal) 's Twitter Profile Photo

Happy New Year! Check out the January issue of LI. nature.com/labinvest/volu… 🔸Mother-to-child transmission of HBV 🔸Advanced detection strategies for cardiotropic virus infection 🔸Bioglass promotes wound healing and much more

Happy New Year! Check out the January issue of LI. 
nature.com/labinvest/volu…
🔸Mother-to-child transmission of HBV
🔸Advanced detection strategies for cardiotropic virus infection
🔸Bioglass promotes wound healing
and much more
Fedaa Najdawi MD (@drfedaa) 's Twitter Profile Photo

"Grade as assessed by the International Medullary Thyroid Carcinoma Grading System IMTCGS is not only prognostic but also reproducible" Check out our publication in Endocrine Pathology, hot off the press! link.springer.com/article/10.100… #endocrinepathology #springer #mtc #pathology

PathAI (@path_ai) 's Twitter Profile Photo

Today at the International Liver Congress, we will be sharing three new posters highlighting our recent, and exciting, research in NASH. #ILC2022

Today at the International Liver Congress, we will be sharing three new posters highlighting our recent, and exciting, research in NASH. #ILC2022